Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Seoyoung Catherine Kim, Sc.D., M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
2014
BWH DOM Early Career Mentoring Award
2014
Harvard Catalyst Clinical Research Center Batch Sample Analysis and Assay Validation Award
2016
Chair's Research Award

Overview
Seoyoung C. Kim, M.D, Sc.D, M.S.C.E, is an Associate Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. She is board-certified in Rheumatology, and co-appointed in the Division of Rheumatology, Immunology and Allergy at Brigham and Women’s Hospital. Her research focuses on comparative safety and effectiveness of medications for the rheumatic diseases as well as health services/outcome research in Rheumatology.
Dr. Kim is one of the Associate Editors for Arthritis Care & Research and has been serving on a number of Committees for the American College of Rheumatology.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AR069557 (KIM, SEOYOUNG CATHERINE) Sep 19, 2016 - Aug 31, 2020
    NIH/NIAMS
    Use and safety of opioids in patients undergoing total joint replacement
    Role: Principal Investigator
  2. R21AR069271 (KIM, SEOYOUNG CATHERINE) Mar 1, 2016 - Feb 28, 2018
    NIH/NIAMS
    Xanthine oxidase inhibitors and risks of myocardial infarction and diabetes
    Role: Principal Investigator
  3. K23AR059677 (KIM, SEOYOUNG CATHERINE) Aug 1, 2010 - Jul 31, 2015
    NIH/NIAMS
    Cervical Dysplasia and Human Papillomavirus Infection in Rheumatoid Arthritis.
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Zhang M, Solomon DH, Desai RJ, Kang EH, Liu J, Neogi T, Kim SC. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol. Circulation. 2018 Sep 11; 138(11):1116-1126. PMID: 29899013.
    View in: PubMed
  2. Rishi J. Desai, Mufaddal Mahesri, Younathan Abdia, Julie Barberio, Angela Tong, Dongmu Zhang, Panagiotis Mavros, Seoyoung C. Kim, Jessica M. Franklin. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. JAMA Network Open. 2018; 3(1):e180826.
  3. Kim SC, Feldman S, Moscicki AB. Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention. Rheumatology (Oxford). 2018 07 01; 57(suppl_5):v26-v33. PMID: 30137592.
    View in: PubMed
  4. Spoendlin J, Schneeweiss S, Tsacogianis T, Paik JM, Fischer MA, Kim SC, Desai RJ. Association of Medicare's Bundled Payment Reform With Changes in Use of Vitamin D Among Patients Receiving Maintenance Hemodialysis: An Interrupted Time-Series Analysis. Am J Kidney Dis. 2018 Aug; 72(2):178-187. PMID: 29891194.
    View in: PubMed
  5. Yu Z, Kim SC, Vanni K, Huang J, Desai R, Murphy SN, Solomon DH, Liao KP. Association between inflammation and systolic blood pressure in RA compared to patients without RA. Arthritis Res Ther. 2018 Jun 01; 20(1):107. PMID: 29855349.
    View in: PubMed
  6. Kang EH, Liao KP, Kim SC. Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis. Curr Rheumatol Rep. 2018 May 30; 20(7):42. PMID: 29846814.
    View in: PubMed
  7. Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, Pinheiro GDRC, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N. Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout. Arthritis Care Res (Hoboken). 2018 May 25. PMID: 29799677.
    View in: PubMed
  8. Jin Y, Kang EH, Brill G, Desai RJ, Kim SC. Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease. J Rheumatol. 2018 Aug; 45(9):1240-1248. PMID: 29764964.
    View in: PubMed
  9. Keller SF, Lu N, Blumenthal KG, Rai SK, Yokose C, Choi JWJ, Kim SC, Zhang Y, Choi HK. Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study. Ann Rheum Dis. 2018 Aug; 77(8):1187-1193. PMID: 29653927.
    View in: PubMed
  10. Lee MP, Lii J, Jin Y, Desai RJ, Solomon DH, Merola JF, Kim SC. Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015. Arthritis Care Res (Hoboken). 2018 May; 70(5):791-796. PMID: 28804988.
    View in: PubMed
  11. Kim SC, Solomon DH, Rogers JR, Gale S, Klearman M, Sarsour K, Schneeweiss S. No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study. Semin Arthritis Rheum. 2018 Mar 22. PMID: 29673963.
    View in: PubMed
  12. Wang P, Smith SE, Garg R, Lu F, Wohlfahrt A, Campos A, Vanni K, Yu Z, Solomon DH, Kim SC. Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT. RMD Open. 2018; 4(1):e000593. PMID: 29556417.
    View in: PubMed
  13. Kim SC, Neogi T, Kang EH, Liu J, Desai RJ, Zhang M, Solomon DH. Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout. J Am Coll Cardiol. 2018 Mar 06; 71(9):994-1004. PMID: 29496000.
    View in: PubMed
  14. Desai RJ, Franklin JM, Spoendlin-Allen J, Solomon DH, Danaei G, Kim SC. An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout. PLoS One. 2018; 13(2):e0193622. PMID: 29489919.
    View in: PubMed
  15. Kim SC, Shah NR, Rogers JR, Bibbo CF, Di Carli MF, Solomon DH. Assessment of coronary vascular function with cardiac PET in relation to serum uric acid. PLoS One. 2018; 13(2):e0192788. PMID: 29438436.
    View in: PubMed
  16. Patorno E, Goldfine AB, Schneeweiss S, Everett BM, Glynn RJ, Liu J, Kim SC. Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study. BMJ. 2018 02 06; 360:k119. PMID: 29437648.
    View in: PubMed
  17. Kang EH, Jin Y, Brill G, Lewey J, Patorno E, Desai RJ, Kim SC. Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study. J Am Heart Assoc. 2018 Jan 24; 7(3). PMID: 29367417.
    View in: PubMed
  18. Bermas BL, Kim SC, Huybrechts K, Mogun H, Hernandez-Diaz S, Bateman BT, Desai RJ. Trends in use of hydroxychloroquine during pregnancy in systemic lupus erythematosus patients from 2001 to 2015. Lupus. 2018 Jan 01; 961203317749046. PMID: 29301469.
    View in: PubMed
  19. Lin TC, Hashemi N, Kim SC, Yang YK, Yoshida K, Tedeschi S, Desai R, Solomon DH. Practice Pattern of Hepatitis B Testing in Rheumatoid Arthritis Patients: A Cross-National Comparison Between the US and Taiwan. Arthritis Care Res (Hoboken). 2018 Jan; 70(1):30-38. PMID: 28320050.
    View in: PubMed
  20. Desai RJ, Gagne JJ, Lii J, Liu J, Friedman S, Kim SC. Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-a inhibitors or nonbiologic agents: a cohort study. CMAJ. 2017 Nov 27; 189(47):E1438-E1447. PMID: 29180383.
    View in: PubMed
  21. Desai RJ, Franklin JM, Kim SC. Alendronate and Hip Fracture in Patients Using Glucocorticoids. JAMA. 2017 11 07; 318(17):1711-1712. PMID: 29114826.
    View in: PubMed
  22. Desai RJ, Solomon DH, Jin Y, Liu J, Kim SC. Temporal Trends in Use of Biologic DMARDs for Rheumatoid Arthritis in the United States: A Cohort Study of Publicly and Privately Insured Patients. J Manag Care Spec Pharm. 2017 Aug; 23(8):809-814. PMID: 28737992.
    View in: PubMed
  23. Jin Y, Desai RJ, Liu J, Choi NK, Kim SC. Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis. Arthritis Res Ther. 2017 07 05; 19(1):159. PMID: 28679392.
    View in: PubMed
  24. Kim SC, Solomon DH, Rogers JR, Gale S, Klearman M, Sarsour K, Schneeweiss S. Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study. Arthritis Rheumatol. 2017 06; 69(6):1154-1164. PMID: 28245350.
    View in: PubMed
  25. Kim SC, Choudhry N, Franklin JM, Bykov K, Eikermann M, Lii J, Fischer MA, Bateman BT. Patterns and predictors of persistent opioid use following hip or knee arthroplasty. Osteoarthritis Cartilage. 2017 09; 25(9):1399-1406. PMID: 28433815.
    View in: PubMed
  26. Levin PA, Nguyen H, Wittbrodt ET, Kim SC. Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research. Diabetes Metab Syndr Obes. 2017; 10:123-139. PMID: 28435305.
    View in: PubMed
  27. Yu EW, Lee MP, Landon JE, Lindeman KG, Kim SC. Fracture Risk After Bariatric Surgery: Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding. J Bone Miner Res. 2017 Jun; 32(6):1229-1236. PMID: 28251687.
    View in: PubMed
  28. Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernandez-Diaz S, Park Y, Dejene SZ, Cohen J, Mogun H, Kim SC. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ. 2017 Mar 06; 356:j895. PMID: 28264814.
    View in: PubMed
  29. Choi NK, Solomon DH, Tsacogianis TN, Landon JE, Song HJ, Kim SC. Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study. J Bone Miner Res. 2017 Mar; 32(3):611-617. PMID: 27736041.
    View in: PubMed
  30. Paik JM, Kim SC, Feskanich D, Choi HK, Solomon DH, Curhan GC. Gout and Risk of Fracture in Women: A Prospective Cohort Study. Arthritis Rheumatol. 2017 02; 69(2):422-428. PMID: 27589491.
    View in: PubMed
  31. Feldman CH, Marty FM, Winkelmayer WC, Guan H, Franklin JM, Solomon DH, Costenbader KH, Kim SC. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications. Arthritis Rheumatol. 2017 02; 69(2):387-397. PMID: 27589220.
    View in: PubMed
  32. Youngster I, Avorn J, Belleudi V, Cantarutti A, Díez-Domingo J, Kirchmayer U, Park BJ, Peiró S, Sanfélix-Gimeno G, Schröder H, Schüssel K, Shin JY, Shin SM, Simonsen GS, Blix HS, Tong A, Trifirò G, Ziv-Baran T, Kim SC. Antibiotic Use in Children - A Cross-National Analysis of 6 Countries. J Pediatr. 2017 03; 182:239-244.e1. PMID: 28012694.
    View in: PubMed
  33. Feldman CH, Liu J, Feldman S, Solomon DH, Kim SC. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs. Lupus. 2017 Jun; 26(7):682-689. PMID: 27799438.
    View in: PubMed
  34. Kim SC, Paik JM, Liu J, Curhan GC, Solomon DH. Gout and the Risk of Non-vertebral Fracture. J Bone Miner Res. 2017 Feb; 32(2):230-236. PMID: 27541696.
    View in: PubMed
  35. Kim SC, Schneeweiss S, Liu J, Karlson EW, Katz JN, Feldman S, Solomon DH. Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Rheumatoid Arthritis: A Cohort Study. Arthritis Rheumatol. 2016 09; 68(9):2106-13. PMID: 27015113; PMCID: PMC5001884 [Available on 09/01/17].
  36. Chingcuanco F, Segal JB, Kim SC, Alexander GC. Bioequivalence of Biosimilar Tumor Necrosis Factor-a Inhibitors Compared With Their Reference Biologics: A Systematic Review. Ann Intern Med. 2016 Oct 18; 165(8):565-574. PMID: 27479870.
    View in: PubMed
  37. Matsuba I, Sawa T, Kawata T, Kanamori A, Jiang D, Machimura H, Takeda H, Han JH, Wang K, Tanaka K, Shen L, Ajima M, Kaneshiro M, Kim SW, Umezawa S, Asakura T, Suzuki S, Kim SC. Cross-National Variation in Glycemic Control and Diabetes-Related Distress Among East Asian Patients Using Insulin: Results from the MOSAIc Study. Diabetes Ther. 2016 Jun; 7(2):349-60. PMID: 27255328; PMCID: PMC4900985.
  38. MacFarlane LA, Liu CC, Solomon DH, Kim SC. Validation of claims-based algorithms for gout flares. Pharmacoepidemiol Drug Saf. 2016 07; 25(7):820-6. PMID: 27230083.
    View in: PubMed
  39. Patorno E, Everett BM, Goldfine AB, Glynn RJ, Liu J, Gopalakrishnan C, Kim SC. Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study. Diabetes Obes Metab. 2016 08; 18(8):755-65. PMID: 27003762.
    View in: PubMed
  40. Desai RJ, Huybrechts KF, Bateman BT, Hernandez-Diaz S, Mogun H, Gopalakrishnan C, Patorno E, Kim SC. Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions. Arthritis Rheumatol. 2016 05; 68(5):1183-9. PMID: 26606742; PMCID: PMC4848128 [Available on 05/01/17].
  41. Kim SC, Choi NK, Lee J, Kwon KE, Eddings W, Sung YK, Ji Song H, Kesselheim AS, Solomon DH. Brief Report: Utilization of the First Biosimilar Infliximab Since Its Approval in South Korea. Arthritis Rheumatol. 2016 05; 68(5):1076-9. PMID: 26662931.
    View in: PubMed
  42. Desai RJ, Solomon DH, Schneeweiss S, Danaei G, Liao KP, Kim SC. Tumor Necrosis Factor-a Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis. Epidemiology. 2016 May; 27(3):414-22. PMID: 26808597.
    View in: PubMed
  43. Kim SC, Kim DH, Mogun H, Eddings W, Polinski JM, Franklin JM, Solomon DH. Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture. J Bone Miner Res. 2016 08; 31(8):1536-40. PMID: 26969902.
    View in: PubMed
  44. Lu N, Rai SK, Terkeltaub R, Kim SC, Menendez ME, Choi HK. Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States. Semin Arthritis Rheum. 2016 10; 46(2):253-8. PMID: 27217070; PMCID: PMC5035554 [Available on 10/01/17].
  45. Solomon DH, Kim SC. Response to: 'Effects of colchicine on risk of cardiovascular events among patients with gout: as evidence accrues, is it time for a randomized trial?' by Giannopoulos and Deftereos. Ann Rheum Dis. 2016 May; 75(5):e29. PMID: 26929220.
    View in: PubMed
  46. Solomon DH, Kim SC. Potential confounding in colchicine and cardiovascular disease study. Ann Rheum Dis. 2016 May; 75(5):e27. PMID: 26873269.
    View in: PubMed
  47. Desai RJ, Solomon DH, Shadick N, Iannaccone C, Kim SC. Identification of smoking using Medicare data--a validation study of claims-based algorithms. Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):472-5. PMID: 26764576; PMCID: PMC4826837 [Available on 04/01/17].
  48. Solomon DH, Liu CC, Kuo IH, Zak A, Kim SC. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims. Ann Rheum Dis. 2016 09; 75(9):1674-9. PMID: 26582823.
    View in: PubMed
  49. Najafzadeh M, Kim SC, Patterson C, Schneeweiss S, Katz JN, Brick GW, Ready JE, Polinski JM, Patorno E. Patients' perception about risks and benefits of antithrombotic treatment for the prevention of venous thromboembolism (VTE) after orthopedic surgery: a qualitative study. BMC Musculoskelet Disord. 2015 Oct 26; 16:319. PMID: 26503220; PMCID: PMC4624375.
  50. Polinski JM, Kim SC, Jiang D, Hassoun A, Shrank WH, Cos X, Rodríguez-Vigil E, Suzuki S, Matsuba I, Seeger JD, Eddings W, Brill G, Curtis BH. Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc). BMC Endocr Disord. 2015 Sep 09; 15:46. PMID: 26353820; PMCID: PMC4563845.
  51. Kim SC, Liu J, Solomon DH. Risk of incident atrial fibrillation in gout: a cohort study. Ann Rheum Dis. 2016 08; 75(8):1473-8. PMID: 26324846.
    View in: PubMed
  52. Feldman CH, Hiraki LT, Winkelmayer WC, Marty FM, Franklin JM, Kim SC, Costenbader KH. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol. 2015 Jun; 67(6):1577-85. PMID: 25772621; PMCID: PMC4446132.
  53. Liao KP, Liu J, Lu B, Solomon DH, Kim SC. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients. Arthritis Rheumatol. 2015 May; 67(8):2004-10. PMID: 25917955; PMCID: PMC4418211.
  54. Kim DH, Rogers JR, Fulchino LA, Kim CA, Solomon DH, Kim SC. Bisphosphonates and risk of cardiovascular events: a meta-analysis. PLoS One. 2015; 10(4):e0122646. PMID: 25884398; PMCID: PMC4401508.
  55. Desai RJ, Solomon DH, Weinblatt ME, Shadick N, Kim SC. An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score. Arthritis Res Ther. 2015 Apr 13; 17:83. PMID: 25880932; PMCID: PMC4394559.
  56. Kesselheim AS, Franklin JM, Kim SC, Seeger JD, Solomon DH. Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population. J Gen Intern Med. 2015 Nov; 30(11):1633-8. PMID: 25855479; PMCID: PMC4617917 [Available on 11/01/16].
  57. Desai RJ, Eddings W, Liao KP, Solomon DH, Kim SC. Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study. Arthritis Care Res (Hoboken). 2015 Apr; 67(4):457-66. PMID: 25302481; PMCID: PMC4751079.
  58. Yoshida K, Solomon DH, Kim SC. Active-comparator design and new-user design in observational studies. Nat Rev Rheumatol. 2015 Jul; 11(7):437-41. PMID: 25800216; PMCID: PMC4486631.
  59. Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C, Clowse M, Curtis JR, Dao K, Hankins GD, Koren G, Kim SC, Lapteva L, Mahadevan U, Moore T, Nolan M, Ren Z, Sammaritano LR, Seymour S, Weisman MH. Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases. Arthritis Care Res (Hoboken). 2015 Mar; 67(3):313-25. PMID: 25385050.
    View in: PubMed
  60. Feldman CH, Hiraki LT, Lii H, Seeger JD, Kim SC. Human papillomavirus vaccine uptake among individuals with systemic inflammatory diseases. PLoS One. 2015; 10(2):e0117620. PMID: 25692470; PMCID: PMC4334247.
  61. Kim SC, Kim MS, Sanfélix-Gimeno G, Song HJ, Liu J, Hurtado I, Peiró S, Lee J, Choi NK, Park BJ, Avorn J. Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med. 2015 May; 128(5):519-26.e1. PMID: 25660252; PMCID: PMC4414898.
  62. Kim SC, Schneeweiss S, Choudhry N, Liu J, Glynn RJ, Solomon DH. Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study. Am J Med. 2015 Jun; 128(6):653.e7-653.e16. PMID: 25660249; PMCID: PMC4442710.
  63. Kim SC, Landon JE, Lee YC. Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia. Arthritis Res Ther. 2015 Jan 28; 17:18. PMID: 25627453; PMCID: PMC4343277.
  64. Xie J, Tong A, Kim SC. Patterns of bisphosphonates utilization in patients under age 45 in a large cohort of commercial insurance beneficiaries in the United States. PLoS One. 2015; 10(1):e0115091. PMID: 25611596; PMCID: PMC4303413.
  65. Kim SC, Liu J, Solomon DH. Risk of incident diabetes in patients with gout: a cohort study. Arthritis Rheumatol. 2015 Jan; 67(1):273-80. PMID: 25332119; PMCID: PMC4384181.
  66. Kim SC, Solomon DH, Liu J, Franklin JM, Glynn RJ, Schneeweiss S. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs. Am J Med. 2015 May; 128(5):539.e7-17. PMID: 25534420; PMCID: PMC4414700.
  67. Polinski JM, Brookhart MA, Ayanian JZ, Katz JN, Kim SC, Lii J, Tonner C, Yelin E, Solomon DH. Relationships between driving distance, rheumatoid arthritis diagnosis, and disease-modifying antirheumatic drug receipt. Arthritis Care Res (Hoboken). 2014 Nov; 66(11):1634-43. PMID: 24664991; PMCID: PMC4175286.
  68. Kim SC, Glynn RJ, Liu J, Everett BM, Goldfine AB. Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study. Acta Diabetol. 2014 Dec; 51(6):1015-23. PMID: 25311055; PMCID: PMC4241160.
  69. MacFarlane LA, Kim SC. Gout: a review of nonmodifiable and modifiable risk factors. Rheum Dis Clin North Am. 2014 Nov; 40(4):581-604. PMID: 25437279; PMCID: PMC4251556.
  70. Gillet VG, Solomon DH, Shadick NA, Weinblatt ME, Iannaccone CK, Feldman S, Kim SC. Behavioral and clinical factors associated with self-reported abnormal Papanicolaou tests in rheumatoid arthritis. J Womens Health (Larchmt). 2014 Sep; 23(9):771-6. PMID: 25203494; PMCID: PMC4158949.
  71. Solomon DH, Tonner C, Lu B, Kim SC, Ayanian JZ, Brookhart MA, Katz JN, Yelin E. Predictors of stopping and starting disease-modifying antirheumatic drugs for rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014 Aug; 66(8):1152-8. PMID: 24470443; PMCID: PMC4112169.
  72. Yelin E, Tonner C, Kim SC, Katz JN, Ayanian JZ, Brookhart MA, Solomon DH. Sociodemographic, disease, health system, and contextual factors affecting the initiation of biologic agents in rheumatoid arthritis: a longitudinal study. Arthritis Care Res (Hoboken). 2014 Jul; 66(7):980-9. PMID: 24339352; PMCID: PMC4124524.
  73. Feldman CH, Kim SC. Should we target patients with autoimmune diseases for human papillomavirus vaccine uptake? Expert Rev Vaccines. 2014 Aug; 13(8):931-4. PMID: 24935354; PMCID: PMC4099266.
  74. Kim SC, Schneeweiss S, Glynn RJ, Doherty M, Goldfine AB, Solomon DH. Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study. Ann Rheum Dis. 2015 Nov; 74(11):1968-75. PMID: 24919467; PMCID: PMC4263684 [Available on 11/01/16].
  75. Kim SC, Glynn RJ, Giovannucci E, Hernández-Díaz S, Liu J, Feldman S, Karlson EW, Schneeweiss S, Solomon DH. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Ann Rheum Dis. 2015 Jul; 74(7):1360-7. PMID: 24618265; PMCID: PMC4161656.
  76. Kim SC, Hernandez-Diaz S. Editorial: Safety of immunosuppressive drugs in pregnant women with systemic inflammatory diseases. Arthritis Rheumatol. 2014 Feb; 66(2):246-9. PMID: 24504795; PMCID: PMC3994991.
  77. Kim SC, Schmidt BM, Franklin JM, Liu J, Solomon DH, Schneeweiss S. Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout. Arthritis Care Res (Hoboken). 2013 Dec; 65(12):2008-14. PMID: 23861232; PMCID: PMC4096791.
  78. Kim SC, Landon JE, Solomon DH. Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalin. Arthritis Care Res (Hoboken). 2013 Nov; 65(11):1813-9. PMID: 23861291; PMCID: PMC4059353.
  79. Kim SC, Schneeweiss S, Liu J, Solomon DH. Risk of venous thromboembolism in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013 Oct; 65(10):1600-7. PMID: 23666917; PMCID: PMC4090802.
  80. Kim SC, Gillet VG, Feldman S, Lii H, Toh S, Brown JS, Katz JN, Solomon DH, Schneeweiss S. Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer. Pharmacoepidemiol Drug Saf. 2013 Nov; 22(11):1239-44. PMID: 24027140; PMCID: PMC3855630.
  81. Kim SC, Yelin E, Tonner C, Solomon DH. Changes in use of disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States during 1983-2009. Arthritis Care Res (Hoboken). 2013 Sep; 65(9):1529-33. PMID: 23463543; PMCID: PMC3717397.
  82. Gedmintas L, Solomon DH, Kim SC. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res. 2013 Aug; 28(8):1729-37. PMID: 23408697; PMCID: PMC3713078.
  83. Kim SC, Liu J, Solomon DH. The risk of atrial fibrillation in patients with rheumatoid arthritis. Ann Rheum Dis. 2014 Jun; 73(6):1091-5. PMID: 23606703; PMCID: PMC3884023.
  84. Kim SC, Newcomb C, Margolis D, Roy J, Hennessy S. Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study. Arthritis Care Res (Hoboken). 2013 Apr; 65(4):578-84. PMID: 22899369; PMCID: PMC3502684.
  85. Schneeweiss S, Rassen JA, Glynn RJ, Myers J, Daniel GW, Singer J, Solomon DH, Kim S, Rothman KJ, Liu J, Avorn J. Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. BMC Med Res Methodol. 2012 Nov 26; 12:180. PMID: 23181419; PMCID: PMC3533513.
  86. Kim SC, Schneeweiss S, Myers JA, Liu J, Solomon DH. No differences in cancer screening rates in patients with rheumatoid arthritis compared to the general population. Arthritis Rheum. 2012 Oct; 64(10):3076-82. PMID: 22782529; PMCID: PMC3462284.
  87. Kim SY, Schneeweiss S, Liu J, Solomon DH. Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study. J Bone Miner Res. 2012 Apr; 27(4):789-96. PMID: 22162140; PMCID: PMC3725780.
  88. Kim SY, Solomon DH. Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments. Arthritis Res Ther. 2011; 13(5):129. PMID: 21996148; PMCID: PMC3308086.
  89. Kim SY, Solomon DH, Liu J, Chang CL, Daniel GW, Schneeweiss S. Accuracy of identifying neutropenia diagnoses in outpatient claims data. Pharmacoepidemiol Drug Saf. 2011 Jul; 20(7):709-13. PMID: 21567653; PMCID: PMC3142869.
  90. Kim SY, Schneeweiss S, Katz JN, Levin R, Solomon DH. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J Bone Miner Res. 2011 May; 26(5):993-1001. PMID: 21542002; PMCID: PMC3179299.
  91. Kim SY, Solomon DH. Pharmacotherapy: comparative safety of nonsteroidal anti-inflammatory drugs. Nat Rev Cardiol. 2011 Apr; 8(4):193-5. PMID: 21436842; PMCID: PMC3725754.
  92. Kim SY, Servi A, Polinski JM, Mogun H, Weinblatt ME, Katz JN, Solomon DH. Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther. 2011 Feb 23; 13(1):R32. PMID: 21345216; PMCID: PMC3241376.
  93. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011 Jan; 63(1):102-10. PMID: 20824805; PMCID: PMC3016454.
  94. Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang CL, Garneau K, Solomon DH. Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther. 2010; 12(4):R154. PMID: 20682035; PMCID: PMC2945054.
  95. Kim SY, Kim MJ, Cadarette SM, Solomon DH. Bisphosphonates and risk of atrial fibrillation: a meta-analysis. Arthritis Res Ther. 2010; 12(1):R30. PMID: 20170505; PMCID: PMC2875664.
  96. Kim SY, Solomon DH. Tumor necrosis factor blockade and the risk of viral infection. Nat Rev Rheumatol. 2010 Mar; 6(3):165-74. PMID: 20142812; PMCID: PMC3155180.
  97. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010 Feb; 62(2):170-80. PMID: 20191515; PMCID: PMC3156692.
  98. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009 Jul 15; 61(7):885-92. PMID: 19565556; PMCID: PMC2714267.
  99. Kim SY, Choi HK. Gout and quality of life. J Rheumatol. 2009 May; 36(5):865-8. PMID: 19435969.
    View in: PubMed
  100. Kim SY, De Vera MA, Choi HK. Gout and mortality. Clin Exp Rheumatol. 2008 Sep-Oct; 26(5 Suppl 51):S115-9. PMID: 19026153.
    View in: PubMed
  101. Akl EA, Kamath G, Yosuico V, Kim SY, Barba M, Sperati F, Cook DJ, Schünemann HJ. Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis. Cancer. 2008 Jun; 112(11):2483-92. PMID: 18404702.
    View in: PubMed
  102. Akl EA, van Doormaal FF, Barba M, Kamath G, Kim SY, Kuipers S, Middeldorp S, Yosuico V, Dickinson HO, Schünemann HJ. Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review. J Exp Clin Cancer Res. 2008 May 15; 27:4. PMID: 18577254; PMCID: PMC2438335.
  103. Kim SY, Linton JM, Kolasinski SL. Successful treatment of new onset Wegener's granulomatosis with IVIG (intravenous immunoglobulin) during pregnancy: a case report. Mod Rheumatol. 2008; 18(2):177-80. PMID: 18299958.
    View in: PubMed
  104. Akl EA, van Doormaal FF, Barba M, Kamath G, Kim SY, Kuipers S, Middeldorp S, Yosuico V, Dickinson HO, Schünemann HJ. Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. Cochrane Database Syst Rev. 2007 Jul 18; (3):CD006652. PMID: 17636846.
    View in: PubMed
  105. Akl EA, Karmath G, Yosuico V, Kim SY, Barba M, Sperati F, Cook D, Schünemann HJ. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. Cochrane Database Syst Rev. 2007 Jul 18; (3):CD006468. PMID: 17636845.
    View in: PubMed
  106. Akl EA, Kamath G, Kim SY, Yosuico V, Barba M, Terrenato I, Sperati F, Schünemann HJ. Oral anticoagulation may prolong survival of a subgroup of patients with cancer: a cochrane systematic review. J Exp Clin Cancer Res. 2007 Jun; 26(2):175-84. PMID: 17725096.
    View in: PubMed
  107. Akl EA, Kamath G, Kim SY, Yosuico V, Barba M, Terrenato I, Sperati F, Schünemann HJ. Oral anticoagulation for prolonging survival in patients with cancer. Cochrane Database Syst Rev. 2007 Apr 18; (2):CD006466. PMID: 17443622.
    View in: PubMed
  108. Kim SY, Martin N, Hsia EC, Pyeritz RE, Albert DA. Management of aortic disease in Marfan Syndrome: a decision analysis. Arch Intern Med. 2005 Apr 11; 165(7):749-55. PMID: 15824293.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (323)
Explore
_
Co-Authors (49)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.